• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌:预后因素

Medullary thyroid carcinoma: prognostic factors.

作者信息

Riddell D A, Lampe H B, Cramer H, Troster M

机构信息

Department of Otolaryngology, University of Western Ontario, London, Canada.

出版信息

J Otolaryngol. 1993 Jun;22(3):180-3.

PMID:7690409
Abstract

Medullary thyroid carcinoma is an uncommon cancer of the thyroid gland. It comprises a neuroendocrine tumor of the calcitonin secreting cells. Its level of aggressiveness lies between that of well-differentiated and anaplastic thyroid malignancies. We have undertaken a retrospective study of 18 patients with medullary thyroid carcinoma to evaluate various parameters for their prognostic value. We looked at epidemiologic factors such as stage, age at onset, sex and the heredity of the disease. In addition various immunohistochemical stains were looked at including Leu-M1, calcitonin, thyroglobulin, somatostatin, carcinoembryonic antigen, neuron specific enolase and BRST-1. Finally, DNA ploidy was determined using the flow cytometer. Stage, age at onset, DNA ploidy and staining for BRST-1 were found to be significant factors in determining outcome of this disease.

摘要

甲状腺髓样癌是一种不常见的甲状腺癌。它是由分泌降钙素的细胞构成的神经内分泌肿瘤。其侵袭性介于高分化和未分化甲状腺恶性肿瘤之间。我们对18例甲状腺髓样癌患者进行了一项回顾性研究,以评估各种参数的预后价值。我们研究了诸如分期、发病年龄、性别和疾病遗传等流行病学因素。此外,还观察了各种免疫组化染色,包括Leu-M1、降钙素、甲状腺球蛋白、生长抑素、癌胚抗原、神经元特异性烯醇化酶和BRST-1。最后,使用流式细胞仪测定DNA倍性。分期、发病年龄、DNA倍性和BRST-1染色被发现是决定该疾病预后的重要因素。

相似文献

1
Medullary thyroid carcinoma: prognostic factors.甲状腺髓样癌:预后因素
J Otolaryngol. 1993 Jun;22(3):180-3.
2
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
3
Prognostic variables and calcitonin in medullary thyroid cancer.甲状腺髓样癌的预后变量与降钙素
Laryngoscope. 2005 Aug;115(8):1445-50. doi: 10.1097/01.mlg.0000168114.90852.a6.
4
[Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].[甲状腺髓样癌的图像分析DNA细胞计量术。与组织形态学参数的比较及预后影响]
Chirurg. 1993 Feb;64(2):122-9.
5
Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.在同一机构接受治疗和随访的高分化甲状腺癌患者的预后因素。
Ann Ital Chir. 2006 Mar-Apr;77(2):107-13.
6
Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.微血管计数:甲状腺髓样癌预后不良的一个指标,但在其他类型的甲状腺癌中并非如此。
Mod Pathol. 1996 Jun;9(6):636-41.
7
[Endocrine therapy and after-care in thyroid gland carcinoma].[甲状腺癌的内分泌治疗及后续护理]
Praxis (Bern 1994). 1998 Mar 11;87(11):389-93.
8
Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.
Acta Chir Scand. 1990 Jan;156(1):37-46.
9
Need for a revised staging consensus in medullary thyroid carcinoma.甲状腺髓样癌分期共识修订的必要性。
Arch Surg. 2009 Jul;144(7):663-9. doi: 10.1001/archsurg.2009.122.
10
Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.通过双色多参数DNA流式细胞术测定309例结直肠癌中DNA倍性和增殖的预后意义。
Cancer. 1997 Jun 1;79(11):2073-86.